Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Corrigendum to "CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis" [Neurobiology of Disease 2019 Nov 5; 134:104630].
Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.
Persistence of mechanoreceptors in ACL remnants: a histological and immunohistochemical analysis of 128 patients.
CD11c+ CD8 T cells cause IFN-γ-dependent autoimmune neuroinflammation that is restrained by PD-1 signaling.
Long-Term Outcomes in Stiff Person Spectrum Disorder.
S3I-201, a STAT3 Inhibitor, Inhibits Proinflammatory Mediator Signalling in CD19 and CD45R/B220 Cells in a Mouse Model of Multiple Sclerosis.
Differences in Income Growth Between People With Multiple Sclerosis and Controls: A Norwegian Cohort Study.
Complement C5 inhibitors as add-on rescue treatment in severe AQP4-antibody neuromyelitis optica spectrum disorder attacks: a case series and literature review.
Prenatal APPV infection delays cerebellar myelination and alters gene expression dynamics during recovery from congenital tremor in pigs.
Workplace difficulties in early-stage relapsing-remitting multiple sclerosis with low physical disability.
Neuroinflammation at the Crossroads of Neurodegeneration: The Roles of Microglia and Astrocytes in Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis.
Beyond EDSS: Memory-guided saccades as candidate digital biomarkers of processing speed and fatigue in MS-A proof-of-concept study.
Mitigating the Impact of MR Sequence Parameters: Increasing the Robustness of DL-Based Cortical Thickness Estimates.
The degenerome-a novel streamline-wise approach for white matter integrity in neurodegeneration.
Reply to the comment on "efficacy and safety of conventional immunosuppressant therapies in elderly patients with neuromyelitis optica spectrum disorder: A target trial emulation study".
Skeletal muscle mitochondrial impairment in patients with newly diagnosed multiple sclerosis revealed by ¹H/³¹P magnetic resonance spectroscopy.
CA1 parvalbumin interneurons display alterations of myelin patterning driven by microgliosis in temporal lobe epilepsy.
The role of neuroimmunology subspecialty in disease management of patients with neuromyelitis optica spectrum disorder.
Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease.
Autoimmune small-vessel cerebral vasculitis with refractory SIADH: clinical recovery after V-receptor antagonism (tolvaptan).
Electronic Health Record-Based Estimates of Acute Disseminated Encephalomyelitis Epidemiology in a Large Healthcare Network, 2000-2025.
Clinical and Modifiable Factors Associated With Disability and Relapse in MOGAD: A Multicentre Cohort Study.
Cladribine use for multiple sclerosis with autoimmune comorbidities: retrospective analysis of the French MS registry, case series, and therapeutic considerations.
Cup-to-Disc Ratio Is Associated with Disability in Multiple Sclerosis: A Combined OCT and Subjective Visual Vertical Study.
Effectiveness of Immersive and Non-Immersive Virtual Reality Interventions on Cognitive Function in People with Multiple Sclerosis: A Systematic Review.

Pages